Ms. Cathy Yen is currently Chairman of Sundia, a leading pre-clinical CRO. Prior to joining Sundia, Ms. Yen had a distinguished career as a successful venture capitalist in Greater China, having led numerous investments and subsequent exits in high-growth companies in the healthcare, semiconductor, media and consumer products sectors. Ms. Yen was responsible for monitoring the strategy and operational performance of her portfolio companies and providing direct assistance in the oversight of large investments. She brings over 25 years of experience in corporate finance, investment banking, strategic planning and venture capital. Ms. Yen received her Bachelor’s degree and MBA from National Taiwan University.
Jim Li, Ph.D.
CEO,Head of Process Chemistry.Dr. Li received his Ph.D in Organic Chemistry from University of Central Lancashire UK followed by postdoctoral fellow at University of Chicago with Philip Eaton. Dr. Li spent more than 18 years at various companies including Henkel, Wyeth, Pfizer, Wuxi Apptec in area of chemical process research and medicinal chemistry on a variety of drug discovery programs such as COPD, asthma, Rheumatoid/osteoarthritis, diabetes and he has co-authored more than 60 research articles and patents.